News

Burrill & Company Announces Close of Burrill Brazil Fund I January 18, 2012 | Press Release

David Wetherell Joins Burrill & Company Venture Capital Group as Managing Director January 06, 2012 | Press Release

Global Financial Market Turmoil Overshadows Biotech Successes in 2011 January 03, 2012 | Press Release

  See all News
 
Sign up to receive email notifications about our upcoming events and news.


Submit a Business Plan

Do great things with us.Click here 
Venture Capital

 


NanoVasc, Inc. is a medical device company that provides technologies that aid patients suffering from vascular diseases. The company's initial application focuses on the debilitating peripheral arterial disease market.